Allergy Therapeutics plc (AGYTF)
OTCMKTS · Delayed Price · Currency is USD
0.1100
+0.0200 (22.22%)
At close: Oct 22, 2025
Allergy Therapeutics Revenue
In the fiscal year ending June 30, 2025, Allergy Therapeutics had annual revenue of 55.04M GBP, down -0.28%. Allergy Therapeutics had revenue of 21.01M in the half year ending June 30, 2025, with 6.75% growth.
Revenue
55.04M GBP
Revenue Growth
-0.28%
P/S Ratio
11.65
Revenue / Employee
94.25K GBP
Employees
584
Market Cap
878.42M USD
Revenue Chart
* This company reports financials in GBP.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 55.04M | -155.00K | -0.28% |
| Jun 30, 2024 | 55.20M | -4.39M | -7.36% |
| Jun 30, 2023 | 59.59M | -13.18M | -18.11% |
| Jun 30, 2022 | 72.77M | -11.56M | -13.71% |
| Jun 30, 2021 | 84.33M | 6.13M | 7.83% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sofgen Pharma | 423.75M |
| Jushi Holdings | 260.43M |
| Glass House Brands | 196.17M |
| MariMed | 157.38M |
| Elite Pharmaceuticals | 122.89M |
| Earth Science Tech | 33.84M |
| Radnostix | 14.07M |
| Healthy Extracts | 3.59M |
Allergy Therapeutics News
- 1 year ago - SMALL CAP IDEA: Allergy Therapeutics transformation has redefined its trajectory - This is Money
- 1 year ago - Global Allergy Therapeutics Market Size To Exceed USD 42.5 Billion By 2033 | CAGR Of 6.29% - GlobeNewsWire
- 4 years ago - Allergy Therapeutics announces FDA clearance of IND application for novel peanut allergy vaccine candidate VLP Peanut - GlobeNewsWire
- 5 years ago - Allergy Therapeutics reports a 6% annualised growth in revenue in fiscal 2020 - Invezz